Skip to main content
Clinical Trials/NCT01801059
NCT01801059CompletedNot Applicable

Patient Activation To Increase Colon Cancer Screening (THE CHAT STUDY)

Ohio State University Comprehensive Cancer Center1 site in 1 country284 target enrollmentStarted: September 1, 2007Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
284
Locations
1
Primary Endpoint
Completion rate of CRC screening

Study Overview

Brief Summary

This randomized clinical trial focused on activating the patient to ask their health care provider for a colorectal cancer screening test to improve screening rates for colorectal cancer. The patient activation intervention may increase information seeking, number of screening tests ordered and number of completed screening tests for colorectal cancer.

Detailed Description

PRIMARY OBJECTIVES:

I. To test a patient activation intervention to improve colorectal cancer (CRC) screening rates using fecal occult blood test (FOBT) among male and female patients 50 years and older from the East Central Columbus Neighborhood Health Center.

SECONDARY OBJECTIVES:

I. To assess if there is a change in knowledge and attitudes about CRC screening after watching the educational video.

II. To assess the effectiveness of providing communication skills training for improving discussion focusing on CRC screening during the patient-provider visit.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
50 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patient is 50+ years of age
  • •Patient is in need of CRC screening
  • •Patient is in good health (e.g. no contraindications to having CRC screening, such as a history of colorectal cancer, congenital heart failure, renal failure, dialysis, dementia, severe arthritis, etc.)
  • •Patient is not pregnant
  • •Patient is able to speak, read, and understand English

Exclusion Criteria

  • •Patient is within CRC screening guidelines
  • •Patient is at high risk for CRC
  • •Patient cannot understand English
  • •Patient cannot complete a CRC screening test

Arms & Interventions

Arm I education CRC and CRC screening

Active Comparator

Educational intervention: Patients receive CRC and CRC screening information from an educational video and received a brochure focused on healthy hints to prevent CRC. Questionnaire administration prior to and after the intervention.

Intervention: educational intervention (Other)

Arm I education CRC and CRC screening

Active Comparator

Educational intervention: Patients receive CRC and CRC screening information from an educational video and received a brochure focused on healthy hints to prevent CRC. Questionnaire administration prior to and after the intervention.

Intervention: questionnaire administration (Other)

Arm II education and patient activation intervention

Experimental

Educational intervention administered: Patients receive patient activation intervention comprising CRC and CRC screening information and communication skills training intervention by educational video and brochure, and they also receive a brochure focused on healthy hints to prevent CRC. Questionnaire administration prior to and after the intervention.

Intervention: educational intervention (Other)

Arm II education and patient activation intervention

Experimental

Educational intervention administered: Patients receive patient activation intervention comprising CRC and CRC screening information and communication skills training intervention by educational video and brochure, and they also receive a brochure focused on healthy hints to prevent CRC. Questionnaire administration prior to and after the intervention.

Intervention: questionnaire administration (Other)

Outcomes

Primary Outcomes

Completion rate of CRC screening

Time Frame: Up to 2 months

A test of two proportions will be used. If the two groups are different at baseline with respect to key covariates, then a logistic regression model will be used to assess the effect of the intervention on CRC screening controlling for possible confounding variables. The variables that differ between the two groups will be tested as confounders using risk-factor modeling. Summary statistics will be used to describe the time point that subjects receive CRC screening, either after the medical visit or after telephone barriers counseling, and relevant comparisons made.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mira Katz

Principal Investigator

Ohio State University Comprehensive Cancer Center

Study Sites (1)

Loading locations...

Similar Trials